Based on 2 analysts offering 12 month price targets for Artelo Biosciences Inc
Min Forecast
$18.00+77.69%
Avg Forecast
$24.00+136.92%
Max Forecast
$30.00+196.15%
Should I buy or sell ARTL stock?
Based on 2 analysts offering ratings for Artelo Biosciences Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ARTL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ARTL as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their ARTL stock forecasts and price targets.
ARTL stock forecasts by analyst
Analyst / Firm
Rating
Action
Price Target
Upside/Downside
Date
Analyst Color
locked
locked
$00.00
+00.00%
2025-08-06
locked
locked
$00.00
+00.00%
2025-03-04
1 of 1
Forecast return on equity
Is ARTL forecast to generate an efficient return?
Company
N/A
Industry
67.72%
Market
-16.88%
Forecast return on assets
Is ARTL forecast to generate an efficient return on assets?
Company
N/A
Industry
22.6%
ARTL earnings per share forecast
What is ARTL's earnings per share in the next 1 years based on estimates from 1 analyst?
Is Artelo Biosciences Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: ARTL) stock is to Strong Buy ARTL stock.
Out of 2 analysts, 1 (50%) are recommending ARTL as a Strong Buy, 1 (50%) are recommending ARTL as a Buy, 0 (0%) are recommending ARTL as a Hold, 0 (0%) are recommending ARTL as a Sell, and 0 (0%) are recommending ARTL as a Strong Sell.
What is ARTL's earnings growth forecast for 2025-2025?
(NASDAQ: ARTL) Artelo Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.68%.
Artelo Biosciences's earnings in 2025 is -$9,715,000.
In 2025, ARTL is forecast to generate -$6,035,900 in earnings, with the lowest earnings forecast at -$6,035,900 and the highest earnings forecast at -$6,035,900.
What is ARTL's forecast return on equity (ROE) for 2025-2027?
(NASDAQ: ARTL) forecast ROE is N/A, which is considered weak.
What is ARTL's Price Target?
According to 2 Wall Street analysts that have issued a 1 year ARTL price target, the average ARTL price target is $24.00, with the highest ARTL stock price forecast at $30.00 and the lowest ARTL stock price forecast at $18.00.
On average, Wall Street analysts predict that Artelo Biosciences's share price could reach $24.00 by Aug 6, 2026. The average Artelo Biosciences stock price prediction forecasts a potential upside of 136.92% from the current ARTL share price of $10.13.
What is ARTL's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ARTL) Artelo Biosciences's current Earnings Per Share (EPS) is -$17.94. In 2025, ARTL's EPS is forecast to hit -$11.04 (min: -$11.04, max: -$11.04).
What is ARTL's forecast return on assets (ROA) for 2025-2027?
(NASDAQ: ARTL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.6%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.